Register information Patent

DE file number : 60 2013 077 422.6 (Status: pending/in force, Query started: April 26, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2013 077 422.6
96EP file numberEAKZ19 16 9275.5
97EP publication numberEPN3533792
54Designation/titleTIKRISTALLINE FORMEN EINES ANDROGENREZEPTORMODULATORS
51IPC main classICM
(ICMV)
C07D 401/04 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61K 31/4439 (2006.01), A61K 31/4184 (2006.01), A61P 35/00 (2006.01)
22DE application dateDATJun 4, 2013
96EP application dateEATJun 4, 2013
43Date of first publicationOTSep 4, 2019
Date of publication of grantPETMay 5, 2021
71/73Applicant/ownerINHAragon Pharmaceuticals, Inc., Los Angeles, CA, US; Sloan Kettering Institute For Cancer Research, New York, NY, US
72InventorINDILHAS, Anna, 4055 Basel, CH; OUERFELLI, Ouathek, Fort Lee, NJ 07024, US; SMITH, Nicholas D., San Diego, CA 92109, US; HERBERT, Mark R., San Diego, CA 92111, US
74RepresentativeVTRMüller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
Address for service Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201261656888 P
Jun 7, 2012
Due dateFT
FG
Jun 30, 2025
Annual fee for the 13th year Patent fees
Patent division in charge 44
21File number of protection certificateZAKZ12 2021 000 067.4
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003533792A1
Searchable text: EP000003533792A1
Original document: EP000003533792B1
Searchable text: EP000003533792B1
43Date of first publicationEVTSep 4, 2019
Date of the first transfer into DPMAregisterEREGTSep 4, 2019
Date of the (most recent) update in DPMAregisterREGTSep 19, 2024
(Show all update days)(Hide all update days)
  • Sep 19, 2024
    • Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 14.05.2024: changed
  • Aug 15, 2024
    • Procedures: Opposition procedure, Patent maintained in full by EPO, 14.05.2024: new
    • Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 14.05.2024: new
  • May 14, 2024; May 10, 2023; May 14, 2022; Mar 31, 2022; Feb 24, 2022; Nov 18, 2021; May 18, 2021; May 5, 2021; Apr 15, 2021
    • Historical data not available for this/these date(s)
  • Sep 4, 2019
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Sep 4, 2019  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Oct 17, 2019 Oct 17, 2019 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) May 5, 2021  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant May 20, 2021 May 20, 2021 Details anzeigen
5 Opposition procedure Opposition to patent filed Feb 4, 2022 Mar 31, 2022 Details anzeigen
6 Opposition procedure Patent maintained full by EPO May 14, 2024  Details anzeigen
7 Opposition procedure Decision by EPO to maintain patent in full has become final May 14, 2024 Sep 19, 2024 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTSep 4, 2019
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTOct 17, 2019
Issue numberHN42
YearPJ2019
Publication dateVTOct 17, 2019
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTMay 5, 2021
Date of update of the procedureREGTApr 15, 2021
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTMay 20, 2021
Issue numberHN20
YearPJ2021
Publication dateVTMay 20, 2021
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTMay 5, 2021
View procedures Opposition procedure (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTOpposition procedure
Legal/procedural statusVSTOpposition to patent filed
Date of legal/procedural statusVSTTFeb 4, 2022
Issue numberHN13
YearPJ2022
Publication dateVTMar 31, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTMar 31, 2022
View procedures Opposition procedure (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTOpposition procedure
Legal/procedural statusVSTPatent maintained full by EPO
Date of legal/procedural statusVSTTMay 14, 2024
Date of update of the procedureREGTAug 15, 2024
View procedures Opposition procedure (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTOpposition procedure
Legal/procedural statusVSTDecision by EPO to maintain patent in full has become final
Date of legal/procedural statusVSTTMay 14, 2024
Issue numberHN38
YearPJ2024
Publication dateVTSep 19, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTSep 19, 2024